Bellevue Group Ag Myriad Genetics Inc Transaction History

Bellevue Group Ag

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$26.93 - $34.7 $859,067 - $1.11 Million	-31,900 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$27.23 - $45.56 $868,637 - $1.45 Million	31,900 New	31,900 $927,000
Q2 2018 Aug 07, 2018	SELL	$27.75 - $40.17 $327,450 - $474,006	-11,800 Closed	0 $0
Q1 2018 May 09, 2018	SELL	$28.83 - $41.01 $5,766 - $8,202	-200 Reduced 1.67%	11,800 $349,000
Q4 2017 Feb 14, 2018	SELL	$28.45 - $37.14 $28,450 - $37,140	-1,000 Reduced 7.69%	12,000 $412,000
Q2 2017 Aug 14, 2017	BUY	N/A	13,000	13,000 $336,000

254

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.3B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

Stay updated on Bellevue Group Ag with notifications on news.